Searchable abstracts of presentations at key conferences in endocrinology

ea0081p292 | Calcium and Bone | ECE2022

Parathyroidectomy decreases serum monocyte chemoattractant protein-1, and increases vitamin d metabolites in patients with primary hyperparathyroidism

Meng Lingqiong , su chi , Shapses Sue A , Trooskin Stanley Z , Wang Xiangbing

Background: Primary hyperparathyroidism (PHPT) is a common endocrine disorder accompanied by high cytokines and low total 25-hydroxyvitamin D [25(OH)D]. An inflammatory cytokine, monocyte chemoattractant protein-1 (MCP-1), is found to be higher in people with elevated parathyroid hormone (PTH), unlike other cytokines (1). Also, a rise in MCP-1 in response to high PTH is associated with bone loss (2). Parathyroidectomy (PTX) is the only cure for patients with PHPT. Whether the ...

ea0011p243 | Cytokines and growth factors | ECE2006

Molecular mechanisms of idiopathic muscle hypertrophy in humans

Solomon AM , Hoffman EP , Ghimbovschi SD , Wang Z , Orrell RW , Goldspink G , Harridge SD , Bouloux PMG

Understanding the molecular factors that regulate human muscle mass is acquiring increasing scientific interest. Hitherto, known (+ve) endocrine regulators of lean body mass included the GH-IGF-1 system, anabolic steroids, and (−ve) myostatin. In order to elucidate this process further, we have investigated a clinical case at a genetic and phenotypic level. A 46-year-old man with idiopathic muscle hypertrophy requiring multiple therapeutic fasciotomies underwent clinical...